A Potent Micron Neoantigen Tumor Vaccine GP‐Neoantigen Induces Robust Antitumor Activity in Multiple Tumor Models

Therapeutic tumor neoantigen vaccines have been widely studied given their good safety profile and ability to avoid central thymic tolerance. However, targeting antigen‐presenting cells (APCs) and inducing robust neoantigen‐specific cellular immunity remain challenges. Here, a safe and broad‐spectru...

Descripción completa

Detalles Bibliográficos
Autores principales: Jing, Zhe, Wang, Shuqing, Xu, Keyuan, Tang, Qian, Li, Wenjing, Zheng, Wei, Shi, Haobo, Su, Kailing, Liu, Yanting, Hong, Zhangyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403634/
https://www.ncbi.nlm.nih.gov/pubmed/35712770
http://dx.doi.org/10.1002/advs.202201496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403634/
https://www.ncbi.nlm.nih.gov/pubmed/35712770
http://dx.doi.org/10.1002/advs.202201496

Ejemplares similares